Crestatin

Indication

Treatment of hypercholesterolaemia

Adults, adolescents and children aged 6 years or older with primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate.

Adults, adolescents and children aged 6 years or older with homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate.

Prevention of Cardiovascular Events

Prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular event (see section 5.1), as an adjunct to correction of other risk factors.

Composition :

5 mg: Each tablet contains 5.198 mg Rosuvastatin Calcium(Eq. to 5 mg Rosuvastatin).

10 mg: Each tablet contains 10.42 mg Rosuvastatin Calcium (Eq. to 10 mg Rosuvastatin).

20 mg: Each tablet contains 20.79 mg Rosuvastatin Calcium (Eq. to 20 mg Rosuvastatin)